ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis
暂无分享,去创建一个
A. Tefferi | T. Lasho | R. Ketterling | A. Pardanani | C. Hanson | D. Zblewski | C. Finke | N. Gangat | R. Abdelrahman | E. Wassie